WK15: HIT coupled with IPE bridges the gap of education and practice between healthcare disciplines through implementing EHR's in simulation centers, allowing for more clinically based realistic education of real time charting during simulation #NURS646FA20
WK13- As a future PMHNP, the use of psychiatric pharmacogenetic testing can provide personalized treatment by using a patient's genotype to aid in determining a therapeutic strategy, appropriate dosage, and assessing the likelihood of benefit or adverse side effects #NURS646FA20
WK10: Front-end CDS tools such as drug–drug interaction checking prove to be both usable and useful for the PMHNP when built in to the EHR by effectively improving decision making at point of care. #NURS646FA20
WK8: For patients with chronic insomnia, Somryst is an FDA approved digital therapeutic available as an app which is intended to improve insomnia by providing neurobehavioral intervention (CBT-I). Available only by prescription, providers can also track progress. #NURS646FA20
WK6: The Go-Live Implementation phase of the SDLC appears to be the biggest challenge in terms of barriers in clinical care. Using detailed planning documents for communication, training, and go-live are critical for success and decision making by the APRN. #NURS646FA20
WK3: Numerous studies show that the increased expenditure on HIE and HER’s is justified through the improvement of patient care quality and reduced cost by reduced utilization of supplies and services. #NURS646FA20
EXP: My expectation for #NURS646FA20 is to better understand how I can use information technology to positively impact patient outcomes when practicing in my future role as an PMHNP
WK1: @AmerPsychNurses encourages PMHNP’s to learn how to harness the limitless potentials of health information technology to further advance our field. #NURS646FA20
M11: Unlike EBP, PBE purposefully allows for practices that match community context and cultural Values. Using PBE such as acupuncture and exercise as adjunct therapy with EBP for depression can yield better patient outcomes. #NURS751
M 10: Studies show that patients experiencing depression who are treated by providers employing a computerized decision support system had significantly greater symptom reduction based on the Hamilton Depression Rating Scale. #NURS751
M9: The APA’s CPG for Treatment of Depression Across Three Age Cohorts is not "policy strong". Treatments for depression are not "one size fits all", too many alternative therapies left out of CPG. Steps 3, 4, 5, 6 not met. #NURS751
M8: Adolescent depression and suicidal ideation can be scary for everyone involved. There in information out there to help. A Parent's Guide to Teen Depression is a good resource https://t.co/MnFFk45RLq
#NURS751#teendepression
Psychology professor Matthias Mehl says it's a mistake to call it social distancing rather than physical distancing. Social interaction – though not in person – is essential at a time like this, for introverts and extroverts alike. https://t.co/8BzCmapAct
M7: Greatest challenge implementing the APA’s Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts would be professional barriers of the providers adopting the CPG. To overcome: identify through assessment, and include them in planning. #NURS751
M6: The Ottawa Model of Research Use (OMRU) created by @IanDGraham1 is an appropriate model to use for implementation of the American Psychological Association's CPG for the Treatment of Depression Across Three Age Cohorts. #NURS751
M5: As a PMHNP, high quality and current CPG's can be referenced to assist clinical decisions, such as for the use of alternative therapies for depression and other disorders. #NURS751
M4: SR and meta-analysis performed by Carter et al. (2016) reviewing exercise and adolescents with depression. EBP: Exercise intervention for both moderate and severe depression in both inpatient and outpatient settings. #NURS751
M3: Both qualitative and quantitative research are valid for EBP and can be used to compliment each other if both are valid, reliable, and address the clinical question appropriately. #NURS751
M2: The Practice Alert on NIBP is Level D per the AACN’s Levels of Evidence. The author's supporting evidence has a high possibility of bias as levels B, D, and E. Implement? Not quite yet, but consider after personal research or a proper guideline is published #NURS751